https://www.has-sante.fr/jcms/p_3523611/fr/resolute-onyx 2024 France health technology assessment Endoprosthesis Cover Zotarolimus Coronary Artery Stent zotarolimus Active Control Active License Coat Stent stents pharmacologist Ethylene-vinyl Alcohol Copolymer-based Embolic Agent Joy pharmacology Product Part Active State Pharmacology zotarolimus Stenting Pet is as Active as it Has Been
--- https://www.has-sante.fr/jcms/p_3512096/fr/resolute-integrity 2024 France health technology assessment Pet is as Active as it Has Been Active State Coronary Artery Stent Pharmacology Zotarolimus Active Control Joy pharmacologist pharmacology Coat Endoprosthesis Stenting zotarolimus Cover Active License stents Stent zotarolimus Product Part
--- https://www.has-sante.fr/jcms/p_3408180/fr/endeavor-resolute 2023 France health technology assessment zotarolimus Endoprosthesis zotarolimus pharmacology stents pharmacologist
--- https://www.has-sante.fr/jcms/p_3372071/fr/onyx-frontier 2022 France health technology assessment pharmacology pharmacologist zotarolimus stents zotarolimus
--- https://www.has-sante.fr/portail/jcms/c_2865967/fr/resolute-onyx 2018 false false false France French health technology assessment stents pharmacology pharmacologic active pharmacologist zotarolimus sirolimus
--- http://www.has-sante.fr/portail/jcms/c_1622853/fr/resolute-integrity http://www.has-sante.fr/portail/jcms/c_1622852/fr/resolute-integrity 2013 France French CORONARY STENT, OTHER health technology assessment Drug-Eluting stents sirolimus zotarolimus coronary artery disease treatment outcome
--- http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000025388591&dateTexte=&categorieLien=id 2012 France legislation zotarolimus sleep apnea syndromes stents societies equipment safety social security traction france aortic stenosis, subvalvular zotarolimus
--- http://www.has-sante.fr/portail/jcms/c_1351909/resolute-integrity 2012 France French CORONARY STENT, OTHER coronary artery disease Drug-Eluting stents zotarolimus sirolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1068127/resolute-integrity-12-juillet-2011-3835-avis http://www.has-sante.fr/portail/jcms/c_1079790/resolute-integrity-12-juillet-2011-3835-avis 2011 France French ACTIVE CORONARY STENT coronary artery disease Drug-Eluting stents sirolimus zotarolimus sirolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1197007/endeavor-resolute-3834-et-resolute-integrity-3835-12-juillet-2011-synthese-d-avis http://www.has-sante.fr/portail/jcms/c_1216278/endeavor-resolute-3834-resolute-integrity-3835-12-juillet-2011-synthese-d-avis 2011 France French ACTIVE CORONARY STENT sirolimus Drug-Eluting stents zotarolimus sirolimus coronary artery disease health technology assessment guidelines for medical devices use treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1067927/endeavor-resolute-12-juillet-2011-3834-avis http://www.has-sante.fr/portail/jcms/c_1079788/endeavor-resolute-12-juillet-2011-3834-avis 2011 France French ACTIVE CORONARY STENT diagnostic uses of chemicals Drug-Eluting stents zotarolimus sirolimus coronary artery disease sirolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1011979/resolute-integrity-21-decembre-2010-3352-avis 2010 France French ACTIVE CORONARY STENT Drug-Eluting stents coronary artery disease zotarolimus sirolimus sirolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_994680/endeavor-resolute-12-octobre-2010-2806-avis http://www.has-sante.fr/portail/jcms/c_994684/endeavor-resolute-12-octobre-2010-2806-avis 2010 France French ACTIVE CORONARY STENT coronary artery disease Drug-Eluting stents zotarolimus sirolimus sirolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1001613/endeavor-et-endeavor-sprint-rx-04-mai-2010-2373-2377-synthese-d-avis http://www.has-sante.fr/portail/jcms/c_1016552/endeavor-endeavor-sprint-04-mai-2010-2373-2377-synthese-d-avis 2010 France French ACTIVE CORONARY STENT Drug-Eluting stents zotarolimus sirolimus sirolimus health technology assessment guidelines for medical devices use treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_716885/endeavor http://www.has-sante.fr/portail/jcms/c_716886/endeavor-cepp-1879 2008 France French ACTIVE CORONARY STENT Drug-Eluting stents sirolimus coronary artery disease zotarolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_671429/endeavor http://www.has-sante.fr/portail/jcms/c_671462/cepp-1744 2008 France French ACTIVE CORONARY STENT Drug-Eluting stents sirolimus angioplasty, balloon, coronary coronary restenosis zotarolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/display.jsp?id=c_522790 2007 France French ACTIVE CORONARY STENT diabetes mellitus sirolimus Drug-Eluting stents coronary stenosis zotarolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/display.jsp?id=c_616564 http://www.has-sante.fr/portail/display.jsp?id=c_616565 2007 France French ACTIVE CORONARY STENT coronary artery disease sirolimus zotarolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/display.jsp?id=c_398739 2006 France French ACTIVE CORONARY STENT diabetes mellitus sirolimus Drug-Eluting stents coronary stenosis zotarolimus health technology assessment treatment outcome